Eterna Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,668,000 and profit margin reached -31865%. Total operating expenses were $20,731,000.
Profit Margin
| 2015 | 24.51M | -7.22M | -29.47% |
|---|---|---|---|
| 2017 | 21.27M | -1.07M | -5.06% |
| 2019 | 19.80M | -2.04M | -10.34% |
| 2020 | 0 | 11.90M | |
| 2021 | 0 | -122.30M | |
| 2022 | 0 | -24.57M | |
| 2023 | 68K | -21.66M | -31864.71% |
BTX Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 68K | 0 | 0 | 0 | 19.80M | 21.27M | 24.51M |
Cost of revenue | 236K | 497K | 459K | 98K | 7.84M | 7.08M | 13.05M |
Gross profit | -168K | -497K | -459K | -98K | 11.96M | 14.18M | 11.46M |
Operating exp. | |||||||
Research and development | 5.92M | 10.39M | 12.70M | 3.95M | 26K | 139K | 0 |
Selling and marketing | 1K | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 20.73M | 27.22M | 27.42M | 7.24M | 13.17M | 15.58M | 18.06M |
Operating income | -21.13M | -33.21M | 68.34M | -7.24M | -1.21M | -1.40M | -6.6M |
Other income (expenses), net | -536K | 8.68M | -190.64M | -19.28M | -808K | 391.00K | -614K |
Income before tax | -21.67M | -24.53M | -122.30M | -7.29M | -2.02M | -1.01M | -7.21M |
Income tax expense | -3K | 45K | 5K | -19.19M | 27K | 66K | 12K |
Net income | -21.66M | -24.57M | -122.30M | 11.90M | -2.04M | -1.07M | -7.22M |
Earnings per share | |||||||
Basic EPS | -4.08 | -8.06 | -56.49 | 27.08 | -28.48 | -17.64 | -157.26 |
Diluted EPS | -4.08 | -8.06 | -56.49 | 27.08 | -28.48 | -17.64 | -157.26 |
| Data source | Data source |